Growth factors: possible roles for clinical management of the short bowel syndrome
- PMID: 20123272
- PMCID: PMC2891767
- DOI: 10.1053/j.sempedsurg.2009.11.010
Growth factors: possible roles for clinical management of the short bowel syndrome
Abstract
The structural and functional changes during intestinal adaptation are necessary to compensate for the sudden loss of digestive and absorptive capacity after massive intestinal resection. When the adaptive response is inadequate, short bowel syndrome (SBS) ensues and patients are left with the requirement for parenteral nutrition and its associated morbidities. Several hormones have been studied as potential enhancers of the adaptation process. The effects of growth hormone, insulin-like growth factor-1, epidermal growth factor, and glucagon-like peptide 2 on adaptation have been studied extensively in animal models. In addition, growth hormone and glucagon-like peptide 2 have shown promise for the treatment of SBS in clinical trials in human beings. Several lesser studied hormones, including leptin, corticosteroids, thyroxine, testosterone, and estradiol, are also discussed.
(c) 2010 Elsevier Inc. All rights reserved.
References
-
- Warner BW, Ziegler MM. Management of the short bowel syndrome in the pediatric population. Pediatr Clin North Am. 1993;40(6):1335–1350. - PubMed
-
- Collins JB, Georgeson KE, Vicente Y, et al. Short bowel syndrome. Semin Pediatr Surg. 1995;4(1):60–72. - PubMed
-
- Williamson RC. Intestinal adaptation (first of two parts). Structural, functional and cytokinetic changes. N Engl J Med. 1978;298(25):1393–1402. - PubMed
-
- Dowling RH, Booth CC. Structural and functional changes following small intestinal resection in the rat. Clin Sci. 1967;32(1):139–149. - PubMed
-
- Dowling RH. Small bowel adaptation and its regulation. Scand J Gastroenterol Suppl. 1982;74:53–74. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources